ConductScience.org, home

Paper10215751

The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency.

Janssen YJ and 2 others. Br J Clin Pharmacol, 1999. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency. Papers, record 10215751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10215751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1999
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2019-05-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Janssen YJY J
2Frölich MM
3Roelfsema FF

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Growth HormoneMajor topic
Human Growth HormoneMajor topic
Absorption
Adult
Area Under Curve
Biological Availability
Dose-Response Relationship, Drug
Female
Humans
Injections, Subcutaneous
Insulin-Like Growth Factor I
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03223025Comparing Efficacy and Safety of CinnaGen Biosimilar Growth Hormone (CinnaTropin®) Versus Nordilet in Children With Idiopathic Growth Hormone DeficiencyBackground

Source ClinicalTrials.gov

Download CSV of trials

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17136757Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats.Acta Physiol Scand1982https://conductscience.org/library/papers/7136757PubMed
23968505Intravenous growth hormone: growth responses to patterned infusions in hypophysectomized rats.J Endocrinol1985https://conductscience.org/library/papers/3968505PubMed
33288652Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.J Clin Endocrinol Metab1988https://conductscience.org/library/papers/3288652PubMed
43389047Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patients.Acta Endocrinol (Copenh)1988https://conductscience.org/library/papers/3389047PubMed
53197637
Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion.
Endocrinology1988https://conductscience.org/library/papers/3197637PubMed
62566779Beneficial effects of growth hormone treatment in GH-deficient adults.Lancet1989https://conductscience.org/library/papers/2566779PubMed
72687691The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.N Engl J Med1989https://conductscience.org/library/papers/2687691PubMed
82189886Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.J Clin Endocrinol Metab1990https://conductscience.org/library/papers/2189886PubMed
91486686The growth hormone deficiency syndrome in adults.Clin Endocrinol (Oxf)1992https://conductscience.org/library/papers/1486686PubMed
108432773Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.J Clin Endocrinol Metab1993https://conductscience.org/library/papers/8432773PubMed
118325945
Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol.
J Clin Endocrinol Metab1993https://conductscience.org/library/papers/8325945PubMed
127514513Pharmacokinetics and metabolic effects of growth hormone injected subcutaneously in growth hormone deficient patients: thigh versus abdomen.Clin Endocrinol (Oxf)1994https://conductscience.org/library/papers/7514513PubMed
137758433Clinical aspects of growth hormone deficiency in adults.Endocr Rev1995https://conductscience.org/library/papers/7758433PubMed
148884873Bioavailability of recombinant human growth hormone in different concentrations and formulations.Pharmacol Toxicol1996https://conductscience.org/library/papers/8884873PubMed
158890721Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administration.Eur J Endocrinol1996https://conductscience.org/library/papers/8890721PubMed
168949572Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH-deficient patients.Clin Endocrinol (Oxf)1996https://conductscience.org/library/papers/8949572PubMed
178989246A low starting dose of genotropin in growth hormone-deficient adults.J Clin Endocrinol Metab1997https://conductscience.org/library/papers/8989246PubMed
189329367
Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficient adults.
J Clin Endocrinol Metab1997https://conductscience.org/library/papers/9329367PubMed
199425397Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults.Clin Endocrinol (Oxf)1997https://conductscience.org/library/papers/9425397PubMed
209626153Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.J Clin Endocrinol Metab1998https://conductscience.org/library/papers/9626153PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
41205697Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP).J Pharm Sci2026https://conductscience.org/library/papers/41205697PubMed
39942773A Reporter Gene Assay for Measuring the Biological Activity of PEGylated Recombinant Human Growth Hormone.Molecules2025https://conductscience.org/library/papers/39942773PubMed
36263321New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36263321PubMed
30893070Increased Human Growth Hormone After Oral Consumption of an Amino Acid Supplement: Results of a Randomized, Placebo-Controlled, Double-Blind, Crossover Study in Healthy Subjects.Am J Ther2020https://conductscience.org/library/papers/30893070PubMed
26408308A Bottom-Up Whole-Body Physiologically Based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins.AAPS J2016https://conductscience.org/library/papers/26408308PubMed
18376417Growth hormone, IGF-I and insulin and their abuse in sport.Br J Pharmacol2008https://conductscience.org/library/papers/18376417PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GH12688PubTator's text mininghttps://conductscience.org/library/genes/2688

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10215751

GET https://conductscience.org/api/papers/v1/10215751/authors